Genetic interactions associated with 12-month atrophy in hippocampus and entorhinal cortex in Alzheimer's Disease Neuroimaging Initiative

Neurobiology of Aging

Volumn 34, Issue 5, 2013, Pages 1518.e9-1518.e18

  Meda, Shashwath A ^a   Koran, Mary Ellen I ^a,b   Pryweller, Jennifer R ^a   Vega, Jennifer N ^a   Thornton Wells, Tricia A ^a  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Biological pathway; Brain atrophy; Epistasis; Gene gene interaction; GWAS; GWIA; KEGG; MRI; Neuroimaging; Pathway based analysis

Indexed keywords

APOLIPOPROTEIN E4; GLYCAN; GONADORELIN; MITOGEN ACTIVATED PROTEIN KINASE;

AGE DISTRIBUTION; AGED; ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CALCIUM SIGNALING; CELL JUNCTION; CLINICAL EVALUATION; CONTROLLED STUDY; EDUCATIONAL STATUS; ENTORHINAL CORTEX; FEMALE; FOCAL ADHESION; GAP JUNCTION; GENE INTERACTION; GENE MAPPING; GENETIC ASSOCIATION; GLIOMA; HIPPOCAMPUS; HUMAN; LONG TERM POTENTIATION; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MELANOGENESIS; MELANOMA; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; PURINE METABOLISM; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE CONTRACTION; WNT SIGNALING PATHWAY;

EID: 84873438019     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.09.020     Document Type: Article

References (47)

1. Akiyama H., Ikeda K., Kondo H., Kato M., McGeer P.L. Microglia express the type 2 plasminogen activator inhibitor in the brain of control subjects and patients with Alzheimer's disease. Neurosci. Lett. 1993, 164:233-235.
2. Belbin O., Carrasquillo M.M., Crump M., Culley O.J., Hunter T.A., Ma L., Bisceglio G., Zou F., Allen M., Dickson D.W., Graff-Radford N.R., Petersen R.C., Morgan K., Younkin S.G. Investigation of 15 of the top candidate genes for late-onset Alzheimer's disease. Hum. Genet. 2011, 129:273-282.
3. Bence N.F., Sampat R.M., Kopito R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 2001, 292:1552-1555.
4. Bi H., Sze C.I. N-methyl-D-aspartate receptor subunit NR2A and NR2B messenger RNA levels are altered in the hippocampus and entorhinal cortex in Alzheimer's disease. J. Neurol. Sci. 2002, 200:11-18.
5. Blurton-Jones M., LaFerla F.M. Pathways by which Abeta facilitates tau pathology. Curr. Alzheimer Res. 2006, 3:437-448.
6. Bossy-Wetzel E., Schwarzenbacher R., Lipton S.A. Molecular pathways to neurodegeneration. Nat. Med. 2004, 10:S2-S9.
7. Camins A., Pallas M., Silvestre J.S. Apoptotic mechanisms involved in neurodegenerative diseases: experimental and therapeutic approaches. Methods Find. Exp. Clin. Pharmacol. 2008, 30:43-65.
8. Carrasquillo M.M., Belbin O., Hunter T.A., Ma L., Bisceglio G.D., Zou F., Crook J.E., Pankratz V.S., Sando S.B., Aasly J.O., Barcikowska M., Wszolek Z.K., Dickson D.W., Graff-Radford N.R., Petersen R.C., Morgan K., Younkin S.G. Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions. J. Alzheimers Dis. 2011, 24:751-758.
9. Chaudhury A.R., Gerecke K.M., Wyss J.M., Morgan D.G., Gordon M.N., Carroll S.L. Neuregulin-1 and erbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease. J. Neuropathol. Exp. Neurol. 2003, 62:42-54.
10. Collingridge G.L., Peineau S., Howland J.G., Wang Y.T. Long-term depression in the CNS. Nat. Rev. Neurosci. 2010, 11:459-473.
11. Convit A., de Leon M.J., Tarshish C., De S.S., Tsui W., Rusinek H., George A. Specific hippocampal volume reductions in individuals at risk for Alzheimer's disease. Neurobiol. Aging 1997, 18:131-138.
12. Craig S., Commins S. The subiculum to entorhinal cortex projection is capable of sustaining both short- and long-term plastic changes. Behav. Brain Res. 2006, 174:281-288.
13. Crews L., Masliah E. Molecular mechanisms of neurodegeneration in Alzheimer's disease. Hum. Mol. Genet. 2010, 19:R12-R20.
14. Devanand D.P., Pradhaban G., Liu X., Khandji A., De S.S., Segal S., Rusinek H., Pelton G.H., Honig L.S., Mayeux R., Stern Y., Tabert M.H., de Leon M.J. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease. Neurology 2007, 68:828-836.
15. Dickerson B.C., Stoub T.R., Shah R.C., Sperling R.A., Killiany R.J., Albert M.S., Hyman B.T., Blacker D., Detoledo-Morrell L. Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults. Neurology 2011, 76:1395-1402.
16. Dubois B., Feldman H.H., Jacova C., DeKosky S.T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Stern Y., Visser P.J., Scheltens P. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007, 6:734-746.
17. Good P.F., Alapat D., Hsu A., Chu C., Perl D., Wen X., Burstein D.E., Kohtz D.S. A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimer's disease. J. Neurochem. 2004, 91:716-736.
18. Hannula-Jouppi K., Kaminen-Ahola N., Taipale M., Eklund R., Nopola-Hemmi J., Kaariainen H., Kere J. The axon guidance receptor gene ROBO1 is a candidate gene for developmental dyslexia. PLoS Genet. 2005, 1:e50.
19. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A., Jones N., Thomas C., Stretton A., Morgan A.R., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Morgan K., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Love S., Kehoe P.G., Hardy J., Mead S., Fox N., Rossor M., Collinge J., Maier W., Jessen F., Schurmann B., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frolich L., Hampel H., Hull M., Rujescu D., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van B.C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Muhleisen T.W., Nothen M.M., Moebus S., Jockel K.H., Klopp N., Wichmann H.E., Carrasquillo M.M., Pankratz V.S., Younkin S.G., Holmans P.A., O'Donovan M., Owen M.J., Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 2009, 41:1088-1093.
20. Herold C., Steffens M., Brockschmidt F.F., Baur M.P., Becker T. INTERSNP: genome-wide interaction analysis guided by a priori information. Bioinformatics 2009, 25:3275-3281.
21. Holland D., Dale A.M. Nonlinear registration of longitudinal images and measurement of change in regions of interest. Med. Image Anal. 2011, 15:489-497.
22. Hollingworth P., Harold D., Sims R., Gerrish A., Lambert J.C., Carrasquillo M.M., Abraham R., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Jones N., Stretton A., Thomas C., Richards A., Ivanov D., Widdowson C., Chapman J., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Beaumont H., Warden D., Wilcock G., Love S., Kehoe P.G., Hooper N.M., Vardy E.R., Hardy J., Mead S., Fox N.C., Rossor M., Collinge J., Maier W., Jessen F., Ruther E., Schurmann B., Heun R., Kolsch H., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frolich L., Hampel H., Gallacher J., Hull M., Rujescu D., Giegling I., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van B.C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Muhleisen T.W., Nothen M.M., Moebus S., Jockel K.H., Klopp N., Wichmann H.E., Pankratz V.S., Sando S.B., Aasly J.O., Barcikowska M., Wszolek Z.K., Dickson D.W., Graff-Radford N.R., Petersen R.C., van Duijn C.M., Breteler M.M., Ikram M.A., DeStefano A.L., Fitzpatrick A.L., Lopez O., Launer L.J., Seshadri S., Berr C., Campion D., Epelbaum J., Dartigues J.F., Tzourio C., Alperovitch A., Lathrop M., Feulner T.M., Friedrich P., Riehle C., Krawczak M., Schreiber S., Mayhaus M., Nicolhaus S., Wagenpfeil S., Steinberg S., Stefansson H., Stefansson K., Snaedal J., Bjornsson S., Jonsson P.V., Chouraki V., Genier-Boley B., Hiltunen M., Soininen H., Combarros O., Zelenika D., Delepine M., Bullido M.J., Pasquier F., Mateo I., Frank-Garcia A., Porcellini E., Hanon O., Coto E., Alvarez V., Bosco P., Siciliano G., Mancuso M., Panza F., Solfrizzi V., Nacmias B., Sorbi S., Bossu P., Piccardi P., Arosio B., Annoni G., Seripa D., Pilotto A., Scarpini E., Galimberti D., Brice A., Hannequin D., Licastro F., Jones L., Holmans P.A., Jonsson T., Riemenschneider M., Morgan K., Younkin S.G., Owen M.J., O'Donovan M., Amouyel P., Williams J. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet. 2011, 43:429-435.
23. Hong M.G., Alexeyenko A., Lambert J.C., Amouyel P., Prince J.A. Genome-wide pathway analysis implicates intracellular transmembrane protein transport in Alzheimer disease. J. Hum. Genet. 2010, 55:707-709.
24. Jack C.R., Petersen R.C., Xu Y., O'Brien P.C., Smith G.E., Ivnik R.J., Tangalos E.G., Kokmen E. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology 1998, 51:993-999.
25. Kesslak J.P., Nalcioglu O., Cotman C.W. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 1991, 41:51-54.
26. Koncina E., Roth L., Gonthier B., Bagnard D. Role of semaphorins during axon growth and guidance. Adv. Exp. Med. Biol. 2007, 621:50-64.
27. LaFerla F.M. Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat. Rev. Neurosci. 2002, 3:862-872.
28. Liu Z.P., Wang Y., Zhang X.S., Chen L. Identifying dysfunctional crosstalk of pathways in various regions of Alzheimer's disease brains. BMC Syst. Biol. 2010, 4(suppl 2):S11.
29. Mattson M.P., Chan S.L. Calcium orchestrates apoptosis. Nat. Cell. Biol. 2003, 5:1041-1043.
30. Mizutani T., Kasahara M. Hippocampal atrophy secondary to entorhinal cortical degeneration in Alzheimer-type dementia. Neurosci. Lett. 1997, 222:119-122.
31. Naj A.C., Jun G., Beecham G.W., Wang L.S., Vardarajan B.N., Buros J., Gallins P.J., Buxbaum J.D., Jarvik G.P., Crane P.K., Larson E.B., Bird T.D., Boeve B.F., Graff-Radford N.R., De Jager P.L., Evans D., Schneider J.A., Carrasquillo M.M., Ertekin-Taner N., Younkin S.G., Cruchaga C., Kauwe J.S., Nowotny P., Kramer P., Hardy J., Huentelman M.J., Myers A.J., Barmada M.M., Demirci F.Y., Baldwin C.T., Green R.C., Rogaeva E., St.George-Hyslop P., Arnold S.E., Barber R., Beach T., Bigio E.H., Bowen J.D., Boxer A., Burke J.R., Cairns N.J., Carlson C.S., Carney R.M., Carroll S.L., Chui H.C., Clark D.G., Corneveaux J., Cotman C.W., Cummings J.L., DeCarli C., DeKosky S.T., Diaz-Arrastia R., Dick M., Dickson D.W., Ellis W.G., Faber K.M., Fallon K.B., Farlow M.R., Ferris S., Frosch M.P., Galasko D.R., Ganguli M., Gearing M., Geschwind D.H., Ghetti B., Gilbert J.R., Gilman S., Giordani B., Glass J.D., Growdon J.H., Hamilton R.L., Harrell L.E., Head E., Honig L.S., Hulette C.M., Hyman B.T., Jicha G.A., Jin L.W., Johnson N., Karlawish J., Karydas A., Kaye J.A., Kim R., Koo E.H., Kowall N.W., Lah J.J., Levey A.I., Lieberman A.P., Lopez O.L., Mack W.J., Marson D.C., Martiniuk F., Mash D.C., Masliah E., McCormick W.C., McCurry S.M., McDavid A.N., McKee A.C., Mesulam M., Miller B.L., Miller C.A., Miller J.W., Parisi J.E., Perl D.P., Peskind E., Petersen R.C., Poon W.W., Quinn J.F., Rajbhandary R.A., Raskind M., Reisberg B., Ringman J.M., Roberson E.D., Rosenberg R.N., Sano M., Schneider L.S., Seeley W., Shelanski M.L., Slifer M.A., Smith C.D., Sonnen J.A., Spina S., Stern R.A., Tanzi R.E., Trojanowski J.Q., Troncoso J.C., Van Deerlin V.M., Vinters H.V., Vonsattel J.P., Weintraub S., Welsh-Bohmer K.A., Williamson J., Woltjer R.L., Cantwell L.B., Dombroski B.A., Beekly D., Lunetta K.L., Martin E.R., Kamboh M.I., Saykin A.J., Reiman E.M., Bennett D.A., Morris J.C., Montine T.J., Goate A.M., Blacker D., Tsuang D.W., Hakonarson H., Kukull W.A., Foroud T.M., Haines J.L., Mayeux R., Pericak-Vance M.A., Farrer L.A., Schellenberg G.D. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 2011, 43:436-441.
32. Neve R.L., McPhie D.L. Dysfunction of amyloid precursor protein signaling in neurons leads to DNA synthesis and apoptosis. Biochim. Biophys. Acta 2007, 1772:430-437.
33. Nyholt D.R. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am. J. Hum. Genet. 2004, 74:765-769.
34. Pennanen C., Kivipelto M., Tuomainen S., Hartikainen P., Hanninen T., Laakso M.P., Hallikainen M., Vanhanen M., Nissinen A., Helkala E.L., Vainio P., Vanninen R., Partanen K., Soininen H. Hippocampus and entorhinal cortex in mild cognitive impairment and early AD. Neurobiol. Aging 2004, 25:303-310.
35. Potkin S.G., Guffanti G., Lakatos A., Turner J.A., Kruggel F., Fallon J.H., Saykin A.J., Orro A., Lupoli S., Salvi E., Weiner M., Macciardi F. Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease. PLoS One 2009, 4:e6501.
36. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 2006, 38:904-909.
37. Pritchard J.K., Stephens M., Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000, 155:945-959.
38. Reiner-Benaim A. FDR control by the BH procedure for two-sided correlated tests with implications to gene expression data analysis. Biom. J. 2007, 49:107-126.
39. Ridha B.H., Barnes J., Bartlett J.W., Godbolt A., Pepple T., Rossor M.N., Fox N.C. Tracking atrophy progression in familial Alzheimer's disease: a serial MRI study. Lancet Neurol. 2006, 5:828-834.
40. Risacher S.L., Shen L., West J.D., Kim S., McDonald B.C., Beckett L.A., Harvey D.J., Jack C.R., Weiner M.W., Saykin A.J. Longitudinal MRI atrophy biomarkers: relationship to conversion in the ADNI cohort. Neurobiol. Aging 2010, 31:1401-1418.
41. Salat D.H., Chen J.J., van der Kouwe A.J., Greve D.N., Fischl B., Rosas H.D. Hippocampal degeneration is associated with temporal and limbic gray matter/white matter tissue contrast in Alzheimer's disease. Neuroimage 2011, 54:1795-1802.
42. Schaffer B.A., Bertram L., Miller B.L., Mullin K., Weintraub S., Johnson N., Bigio E.H., Mesulam M., Wiedau-Pazos M., Jackson G.R., Cummings J.L., Cantor R.M., Levey A.I., Tanzi R.E., Geschwind D.H. Association of GSK3B with Alzheimer disease and frontotemporal dementia. Arch. Neurol. 2008, 65:1368-1374.
43. Shen L., Kim S., Risacher S.L., Nho K., Swaminathan S., West J.D., Foroud T., Pankratz N., Moore J.H., Sloan C.D., Huentelman M.J., Craig D.W., Dechairo B.M., Potkin S.G., Jack C.R., Weiner M.W., Saykin A.J. Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: a study of the ADNI cohort. Neuroimage 2010, 53:1051-1063.
44. Shi H., Belbin O., Medway C., Brown K., Kalsheker N., Carrasquillo M., Proitsi P., Powell J., Lovestone S., Goate A., Younkin S., Passmore P., Morgan K. Genetic variants influencing human aging from late-onset Alzheimer's disease (LOAD) genome-wide association studies (GWAS). Neurobiol. Aging 2012, 33:1849.e5-1849.e18.
45. Sleegers K., Lambert J.C., Bertram L., Cruts M., Amouyel P., Van B.C. The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects. Trends Genet. 2010, 26:84-93.
46. von Mering C., Jensen L.J., Snel B., Hooper S.D., Krupp M., Foglierini M., Jouffre N., Huynen M.A., Bork P. STRING: known and predicted protein-protein associations, integrated and transferred across organisms. Nucleic Acids Res. 2005, 33:D433-D437.
47. Wall D.P., Pivovarov R., Tong M., Jung J.Y., Fusaro V.A., DeLuca T.F., Tonellato P.J. Genotator: a disease-agnostic tool for genetic annotation of disease. BMC Med. Genomics 2010, 3:50.